Blog

Pashtoon Kasi: Our paper with more than 10,000 accesses ranks at N1 in Oncogene Journal

Photo from Pashtoon Kasi / X

Dec 20, 2023, 09:57

Pashtoon Kasi: Our paper with more than 10,000 accesses ranks at N1 in Oncogene Journal

Pashtoon Kasi, the Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on X:

“Our paper with more than 10,000 accesses ranks at N1 in Oncogene Journal.

Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient (pMMR/MSS) colorectal cancer.

Link: https://nature.com/articles/s41388-023-02835-y

GI24 will present full NEST-1 cohort.”

Source: Pashtoon Kasi / X

Balstilimab botensilimab botensilimab plus balstilimab cancer colorectal cancer Colorectal Cancer Research immunotherapy immunotherapy for colorectal cancer mismatch repair proficient Neoadjuvant botensilimab plus balstilimab OncoDaily Oncogene journal Oncology Pashtoon Kasi Weill Cornell Medicine

New Paper Alert! HR+ Breast Cancer: Efficacy of Subsequent Treatments After CDK4/6 Inhibitor Progression

Carlos Rodriguez-Galindo: The Man Who Will Cure the World

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

Special Coverage